Neutra (NTRR) 10-Q/A24 Dec 132014 Q3 Quarterly report (amended)Financial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Oct. 31, 2013	Dec. 18, 2013
Document and Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Oct-13	'
Entity Registrant Name	'NEUTRA CORP.	'
Entity Central Index Key	'0001512886	'
Current Fiscal Year End Date	'--01-31	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	12,004,515

Balance_Sheets

Balance Sheets (USD $)	Oct. 31, 2013	Jan. 31, 2013
CURRENT ASSETS	'	'
Cash and cash equivalents	$91,087	$7,100
Total current assets	91,087	7,100
TOTAL ASSETS	91,087	7,100
CURRENT LIABILITIES	'	'
Accounts payable and accrued liabilities	122,737	83,506
Accounts payable and accrued liabilities - related party	5,700	'
Advances payable	'	179,485
Total current liabilities	128,437	262,991
Convertible note payable, net of current portion and discount of $837,117 and $37,721	84,778	9,484
Total liabilities	213,215	272,475
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Common stock, $0.0001 par value, 100,000,000 shares authorized 11,904,515 and 4,949,515 shares issued and outstanding at October 31, 2013 and January 31, 2013, respectively	1,191	495
Additional paid-in capital	1,171,907	183,700
Deficit accumulated during the development stage	-1,295,226	-449,570
Total Stockholders' Equity (Deficit)	-122,128	-265,375
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$91,087	$7,100

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Oct. 31, 2013	Jan. 31, 2013
Debt Instrument [Line Items]	'	'
Common stock, par value per share	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	11,904,515	4,949,515
Common stock, shares outstanding	11,904,515	4,949,515
Convertible note payable, net of current portion [Member]	'	'
Debt Instrument [Line Items]	'	'
Unamortized discount on convertible note payable	$837,117	$37,721

Statements_of_Operations

Statements of Operations (USD $)	3 Months Ended		9 Months Ended		34 Months Ended
Statements of Operations (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
OPERATING EXPENSES	'	'	'	'	'
General and administrative	$273,511	$50,645	$705,532	$229,527	$1,097,403
Net loss from operations	-273,511	-50,645	-705,532	-229,527	-1,097,403
Other income (expense)	'	'	'	'	'
Interest expense	-76,257	-47,432	-140,124	-52,519	-197,823
Net loss	($349,768)	($98,077)	($845,656)	($282,046)	($1,295,226)
PER SHARE DATA:	'	'	'	'	'
Basic and diluted loss per common share	($0.03)	($0.03)	($0.10)	($0.19)	'
Basic and diluted weighted average common shares outstanding	10,841,472	3,152,982	8,532,354	1,457,213	'

Statements_of_Stockholders_Equ

Statements of Stockholders' Equity (Deficiency) (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Deficit Accumulated During The Development Stage [Member]
Balance at Jan. 10, 2011	'	'	'	'
Balance, shares at Jan. 10, 2011	'	'	'	'
Common shares issued to Founder for cash at $0.02 per share (par value $0.0001) on January 11, 2011	9,000	45	8,955	'
Common shares issued to Founder for cash at $0.02 per share (par value $0.0001) on January 11, 2011, shares	450,000	450,000	'	'
Net loss	-2,600	'	'	-2,600
Balance at Jan. 31, 2011	6,400	45	8,955	-2,600
Balance, shares at Jan. 31, 2011	'	450,000	'	'
Common shares issued to investors for cash on June 1, 2011 at $0.2733 per share	41,000	15	40,985	'
Common shares issued to investors for cash on June 1, 2011 at $0.2733 per share, shares	'	150,011	'	'
Net loss	-81,216	'	'	-81,216
Balance at Jan. 31, 2012	-33,816	60	49,940	-83,816
Balance, shares at Jan. 31, 2012	'	600,011	'	'
Share correction related to reverse split, shares	'	4	'	'
Common stock issued for conversion of note payable	43,495	435	43,060	'
Common stock issued for conversion of note payable, shares	'	4,349,500	'	'
Discount on convertible note payable	90,700	'	90,700	'
Net loss	-365,754	'	'	-365,754
Balance at Jan. 31, 2013	-265,375	495	183,700	-449,570
Balance, shares at Jan. 31, 2013	'	4,949,515	'	'
Common stock issued for conversion of note payable	69,550	696	68,854	'
Common stock issued for conversion of note payable, shares	'	6,955,000	'	'
Discount on convertible note payable	919,353	'	919,353	'
Net loss	-845,656	'	'	-845,656
Balance at Oct. 31, 2013	($122,128)	$1,191	$1,171,907	($1,295,226)
Balance, shares at Oct. 31, 2013	'	11,904,515	'	'

Statements_of_Stockholders_Equ1

Statements of Stockholders' Equity (Deficiency) (Parenthetical) (USD $)	1 Months Ended		12 Months Ended
	Jun. 01, 2011	Jan. 31, 2011	Jan. 31, 2012
Statements of Stockholders' Equity (Deficiency) [Abstract]	'	'	'
Common stock issued for cash, price per share	$0.27	$0.02	$0.27

Statements_of_Cash_Flow

Statements of Cash Flow (USD $)	9 Months Ended		34 Months Ended
Statements of Cash Flow (USD $)	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Operating activities	'	'	'
Net loss	($845,656)	($282,046)	($1,295,226)
Adjustments to reconcile net loss to net cash used by operating activities:	'	'	'
Amortization of discount on convertible note payable	119,957	50,346	172,936
Changes in operating assets and liabilities:	'	'	'
Accrued interest payable	20,167	2,173	20,167
Accounts payable and accrued liabilities	43,951	11,055	127,457
Accounts payable and accrued liabilities - related party	5,700	'	5,700
Net cash used by operating activities	-655,881	-218,472	-968,966
Investing activities	'	'	'
Net cash used by investing activities	'	'	'
Financing activities	'	'	'
Proceeds from advances	739,868	197,200	1,010,053
Proceeds from issuance of common stock	'	'	50,000
Net cash provided by financing activities	739,868	197,200	1,060,053
Net increase (decrease) in cash	83,987	-21,272	91,087
Cash at beginning of period	7,100	28,852	'
Cash at end of period	91,087	7,580	91,087
Supplemental disclosures of cash flow information and non-cash investing and financing activities:	'	'	'
Conversion of advances into convertible notes payable	69,550	90,700	160,250
Conversion of convertible notes payable into common stock	$919,353	$43,495	$962,848

GENERAL_ORGANIZATION_AND_BUSIN

GENERAL ORGANIZATION AND BUSINESS	9 Months Ended
GENERAL ORGANIZATION AND BUSINESS	Oct. 31, 2013
GENERAL ORGANIZATION AND BUSINESS [Abstract]	'
GENERAL ORGANIZATION AND BUSINESS	'
	NOTE 1. GENERAL ORGANIZATION AND BUSINESS

	We are a development stage company and were incorporated in the State of Florida on January 11, 2011, as a for-profit company, and an established fiscal year end of January 31. We intend to market and sell nutraceutical supplement products to health practitioners. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. To date, we have not approached a contractor to have any of our intended private label brand supplement products.

	Our intended strategy is to build brand recognition by providing the healthcare practitioners with education and support and in turn the healthcare practitioner with education and support will hopefully recommend our products to their patients. We intend to accomplish this education and support process providing regular and frequent access to educational tools, such as webinars and live seminars. Although practitioners may have several supplement brands in their dispensary when it comes to the moment of choice for that difficult patient and others, we are hoping that our strategy of providing good service and educational support they choose us.

	We have not generated any revenue to date and our activities have been limited to developing the business plan, launching our website, hiring consultants and advisors, establishing an office and beginning research and development of products. We will not have the necessary capital to develop our business plan until we are able to secure additional financing.

	Neutra Corp. is in the early stage of implementing its business plan. The Company does not have any products, customers and has not generated any revenues. The Company must complete the business plan, develop the product and attract customers before it can start generating revenues.

	On January 11, 2013, the Company executed an Option Agreement with Purlife Distributors Inc., and authorized distributor of DrivePur and Purteq products in Canada, (hereafter referred to as "Purlife". Purlife owns rights to market, in Canada, environmentally-friendly, sustainable and long-lasting antimicrobial solutions for indoor and outdoor surfaces. The Option Agreement shall be for a period of ninety (90) days beginning from the date of the agreement. The Company will pay Purlife a $5,000 non-refundable payment. Under the option agreement, the Company, will have the right to conduct a due diligence review of Purlife with complete access to data, patent applications, financial statements and other pertinent information. From the Option Agreement, the Company was able to form a Joint Venture with Purlife on February 1, 2013.

	Through October 31, 2013, the Company was in the development stage and has not generated revenues. The Company has incurred losses since inception aggregating $1,295,226. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern.

GOING_CONCERN

GOING CONCERN	9 Months Ended
GOING CONCERN	Oct. 31, 2013
GOING CONCERN [Abstract]	'
GOING CONCERN	'
	NOTE 2. GOING CONCERN

	For the nine months ended October 31, 2013, the Company had a net loss of $845,656 and negative cash flow from operations of $655,881. As of October 31, 2013, the Company has negative working capital of $37,350. The Company has not emerged from the development stage.

	These factors raise a substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

	The Company does not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the Company will not be able to remain in business.


	Management has plans to address the Company's financial situation as follows:

	In the near term, management plans to continue to focus on raising the funds necessary to fully implement the Company's business plan. Management will continue to seek out debt financing to obtain the capital required to meet the Company's financial obligations. There is no assurance, however, that lenders will continue to advance capital to the Company or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raises doubts about the Company's ability to continue as a going concern.

	In the long term, management believes that the Company's projects and initiatives will be successful and will provide cash flow to the Company which will be used to finance the Company's future growth. However, there can be no assurances that the Company's planned activities will be successful, or that the Company will ultimately attain profitability. The Company's long term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and the ability of the Company to ultimately achieve adequate profitability and cash flows from operations to sustain its operations.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES	9 Months Ended
	Oct. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES	'
	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES

	The significant accounting policies followed are:

	Development Stage Entity - The Company is a development stage company as defined by FASB ASC 915, Development Stage Entities. The Company is still devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since inception have been considered as part of the Company's development stage activities.

	Interim Financial Statements - The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such statements are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended January 31, 2013 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the "SEC"). The results of operations for the period ended October 31, 2013 are not necessarily indicative of the results for the full fiscal year ending January 31, 2014.

	Use of estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

	Cash and cash equivalents - All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. Cash and cash equivalents were $91,087 and $7,100 at October 31, 2013 and 2012, respectively.

	Common stock - The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

	Income Taxes - The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of October 31, 2013 or January 31, 2013.


	Earnings (Loss) Per Share - Basic loss per share is computed in accordance with ASC Topic 260, Earnings per Share, by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered antidilutive and thus are excluded from the calculation. At October 31, 2013 and 2012, the Company did not have any potentially dilutive common shares.

	Related Parties - The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Related party transactions for the periods ended October 31, 2013 and 2012 totaled $0.

	Financial instruments - The Company's balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

	ASC 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:


		·	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

		·	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

		·	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company's notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.

	Recent Accounting Pronouncements

	In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:



	·	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and

	·	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.

	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected to have a material impact on our financial position or results of operations.

	In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.

JOINT_VENTURE

JOINT VENTURE	9 Months Ended
JOINT VENTURE	Oct. 31, 2013
JOINT VENTURE [Abstract]	'
JOINT VENTURE	'
	NOTE 4. JOINT VENTURE

	On February 1, 2013, the Company entered into a Joint Venture Agreement with Purlife. The Joint Venture was created towards developing and marketing the brands represented by Purlife. Purlife will execute the business plan or other programs as agreed to as well as make any necessary disbursements on behalf of the Joint Venture, and collect and distribute profits in accordance with the ownership percentages. The Joint Venture will allocate profits for a period of 3 years with the Company receiving 10% and the Joint Venture receiving 90%. All loss and disbursements incurred by Purlife in acquiring, holding and protecting the business interest and the net profits shall, during the period of the venture be paid by Purlife. All losses incurred by the Parties will be limited to their financial contribution to the Joint Venture. The Company will provide consulting to the Joint Venture and participate in strategic and operation decisions as required.

	The Company will be a way of providing start up and operating expenses such as to facilitate the completion of the undertaking of the Business.

	During the nine months ended October 31, 2013, the Company paid a total of $150,000 to fund the cash flow requirements as set forth in an approved budget prepared by Purlife. These payments are included in general and administrative expense on the statement of operations. The Company has no further obligation to continue funding.

	On May 30, 2013, the Company entered into a joint venture agreement with Field of View Technologies, LLC. (the "Field of View JV"). The purpose of the Field of View JV is to develop, produce and market a new cannabis inhalation delivery system. Under the terms of the agreement, the Company will provide funding for the project and provide consulting services to the Field of View JV. Field of View Technologies, LLC will develop the product and manage the joint venture. In exchange, the Company will receive 25% of the profit on all inhalation cannabinoid delivery systems for a period of 36 months. The Company has committed to fund $175,000 of the costs of the Field of View JV. During the nine months ended October 31, 2013, the Company paid a total of $55,000 under the Field of View JV. These payments are included in general and administrative expense on the statement of operations.

	On June 5, 2013, the Company entered into a joint venture agreement with Vertigo Technologies, LLC. (the "Vertigo JV"). The purpose of the Vertigo JV is to develop, produce and market a new cannabis inhalation delivery system. Under the terms of the agreement, the Company will provide funding for the project. Vertigo Technologies, LLC will develop the product and manage the joint venture. In exchange, the Company will receive 30% of the profit on all inhalation cannabinoid delivery systems for a period of 36 months. The Company has committed to fund $85,000 of the costs of the Vertigo JV. During the nine months ended October 31, 2013, the Company paid a total of $65,000 under the Vertigo JV. These payments are included in general and administrative expense on the statement of operations.


	On August 25, 2013, the Company entered into a joint venture agreement with Second Wave Ventures, LLC. (the "Second Wave JV"). The purpose of the Second Wave JV is to develop, produce and market nutraceutical products and deliver systems. Under the terms of the agreement, the Company will provide funding for the operations of the joint venture. In exchange, the Company will receive 30% of the profits on all products and delivery systems within the nutraceutical market. The Company has committed to fund $85,000 under the Second Wave JV which will be paid in weekly payments of $5,000. During the nine months ended October 31, 2013, the Company paid a total of $30,000 under the Second Wave JV. These payments are included in general and administrative expense on the statement of operations.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Oct. 31, 2013
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	NOTE 5. RELATED PARTY TRANSACTIONS

	During the nine months ended October 31, 2013, the Company accrued salary of $75,000 to Sydney Jim, our Chief Executive Officer and $30,000 to Cindy Morrissey, our former Chief Executive Officer. During the nine months ended October 31, 2012, the Company accrued salary of $62,500 to Ms. Morrissey and $19,000 to Sara Keck, our former Chief Executive Officer.

	As of October 31, 2013 and January 31, 2013, the Company owed Mr. Jim $5,700 and $0, respectively, for unpaid salary and expenses. This amount was paid in November 2013.

CONVERTIBLE_NOTES_PAYABLE

CONVERTIBLE NOTES PAYABLE	9 Months Ended
CONVERTIBLE NOTES PAYABLE	Oct. 31, 2013
CONVERTIBLE NOTES PAYABLE [Abstract]	'
CONVERTIBLE NOTES PAYABLE	'
	NOTE 6. CONVERTIBLE NOTES PAYABLE

	On February 28, 2013, the Company signed a Convertible Promissory Note which refinanced non-interest bearing advances in the amount of $104,650 into a convertible note payable. The Convertible Promissory Note bears interest at 10% per annum and is payable along with accrued interest on February 28, 2015. The Convertible Promissory Note is convertible into common stock at the option of the holder at the rate of $0.01 per share.

	On July 31, 2013, the Company signed a Convertible Promissory Note which refinanced non-interest bearing advances in the amount of $338,815 into a convertible note payable. The Convertible Promissory Note bears interest at 10% per annum and is payable along with accrued interest on July 31, 2015. The Convertible Promissory Note is convertible into common stock at the option of the holder at the rate of $0.05 per share.

	On October 31, 2013, the Company signed a Convertible Promissory Note which refinanced non-interest bearing advances in the amount of $475,888 into a convertible note payable. The Convertible Promissory Note bears interest at 10% per annum and is payable along with accrued interest on October 31, 2015. The Convertible Promissory Note is convertible into common stock at the option of the holder at the rate of $0.05 per share.

	The Company evaluated the application of ASC 470-50-40/55, Debtor's Accounting for a Modification or Exchange of Debt Instrument as it applies to the notes listed above and concluded that the revised terms constituted a debt modification rather than a debt extinguishment because the present value of the cash flow under the terms of the new instruments was less than 10% from the present value of the remaining cash flows under the terms of the original notes. No gain or loss on the modifications was required to be recognized.

	The Company evaluated the terms of the new notes in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity's Own Stock and determined that the underlying common stock is indexed to the Company's common stock. The Company determined that the conversion features did not meet the definition of a liability and therefore did not bifurcate the conversion feature and account for it as a separate derivative liability. The Company evaluated the conversion feature for a beneficial conversion feature. The effective conversion price was compared to the market price on the date of the note and was deemed to be less than the market value of underlying common stock at the inception of the note. Therefore, the Company recognized beneficial conversion features in the amount of $104,650, $338,815 and $475,888 on February 28, 2013, July 31, 2013 and October 31, 2013, respectively. The beneficial conversion feature was recorded as an increase in additional paid-in capital and a discount to the Convertible Notes Payable. The discount to the Convertible Notes Payable will be amortized to interest expense over the life of the note.

	During the nine months ended October 31, 2013, the holders of the Convertible Note Payable dated February 1, 2012, elected to convert principal and accrued interest in the amounts shown below into shares of common stock at a rate of $0.01 per share. On the conversion date, the unamortized discount related to the principal amount converted was immediately amortized to interest expense. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement.



	Date	Amount Converted		Number of	Unamortized Discount
	Date	Amount Converted		Shares Issued	Unamortized Discount
	6-Feb-13	$	4,900	490,000	$	3,920
	12-Mar-13		4,900	490,000		3,803
	20-Mar-13		5,900	590,000		4,503
	15-Apr-13		6,500	650,000		4,822
	3-May-13		3,250	325,000		2,281
	17-May-13		3,700	370,000		2,580
	22-May-13		3,700	370,000		2,494
	13-Jun-13		3,700	370,000		2,407
	14-Jun-13		4,000	400,000		2,489
	24-Jun-13		4,000	400,000		2,477
	1-Aug-13		4,000	400,000		1,312
	13-Aug-13		8,000	800,000		-

	Total	$	56,550	5,655,000	$	33,088

	During the nine months ended October 31, 2013, the holders of the Convertible Note Payable dated February 28, 2013, elected to convert principal and accrued interest in the amounts shown below into shares of common stock at a rate of $0.01 per share. On the conversion date, the unamortized discount related to the principal amount converted was immediately amortized to interest expense. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement.


	Date	Amount Converted		Number of	Unamortized Discount
	Date	Amount Converted		Shares Issued	Unamortized Discount
	17-Sep-13	$	4,000	400,000	$	-
	1-Oct-13		4,000	400,000		1,300
	25-Oct-13		5,000	500,000		3,193

	Total	$	13,000	1,300,000	$	5,978

COMMON_STOCK

COMMON STOCK	9 Months Ended
COMMON STOCK	Oct. 31, 2013
COMMON STOCK [Abstract]	'
COMMON STOCK	'
	NOTE 7. COMMON STOCK

	On January 11, 2011, The Company issued 450,000 shares of common stock to the founder for cash proceeds of $9,000.

	On June 1, 2011, the Company issued 150,011 shares of common stock for cash proceeds of $41,000.

	On August 8, 2012, the Company effected a one-for-20 reverse stock split. All share and per share amounts have been restated to reflect the reverse split.

	On September 7, 2012, the holder of the convertible note payable dated August 31, 2012 elected to convert the entire principal balance of $43,495 into 4,349,500 shares of common stock.

	On February 6, 2013, the Company issued 490,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,900.

	On March 12, 2013, the Company issued 490,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,900.

	On March 20, 2013, the Company issued 590,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $5,900.

	On April 15, 2013, the Company issued 650,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $6,500.


	On May 3, 2013, the Company issued 325,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $3,250.

	On May 17, 2013, the Company issued 370,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $3,700.

	On May 22, 2013, the Company issued 370,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $3,700.

	On June 13, 2013, the Company issued 370,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $3,700.

	On June 14, 2013, the Company issued 400,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,000.

	On June 24, 2013, the Company issued 400,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,000.

	On August 1, 2013, the Company issued 400,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,000.

	On August 13, 2013, the Company issued 800,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $8,000.

	On September 17, 2013, the Company issued 400,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,000.

	On October 1, 2013, the Company issued 400,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $4,000.

	On October 25, 2013, the Company issued 500,000 shares of common stock as a result of the conversion of a convertible note payable in the amount of $5,000.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Oct. 31, 2013
SUBSEQUENT EVENTS [Abstract]	'
SUBSEQUENT EVENTS	'
	NOTE 8 . SUBSEQUENT EVENTS

	On November 8, 2013, the holder of the convertible note payable dated February 28, 2013, elected to convert principal in the amount of $4,000 into 400,000 shares of common stock in accordance with the terms of the note payable. As a result of the conversion, unamortized discount associated with the converted principal in the amount of $2,435 was immediately amortized to interest expense. There was no gain or loss recognized on the conversion as it was effected in accordance with the terms of the convertible note payable

	On December 4, 2013, the holder of the convertible note payable dated February 28, 2013, elected to convert principal in the amount of $5,000 into 500,000 shares of common stock in accordance with the terms of the note payable. As a result of the conversion, unamortized discount associated with the converted principal in the amount of $2,697 was immediately amortized to interest expense. There was no gain or loss recognized on the conversion as it was effected in accordance with the terms of the convertible note payable

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policy)	9 Months Ended
	Oct. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]	'
Development Stage Entity	'
	Development Stage Entity - The Company is a development stage company as defined by FASB ASC 915, Development Stage Entities. The Company is still devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since inception have been considered as part of the Company's development stage activities.
Interim Financial Statements	'
	Interim Financial Statements - The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such statements are of a normal recurring nature. These financial statements should be read in conjunction with the financial statements for the year ended January 31, 2013 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the "SEC"). The results of operations for the period ended October 31, 2013 are not necessarily indicative of the results for the full fiscal year ending January 31, 2014.

Use of estimates	'
	Use of estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and cash equivalents	'
	Cash and cash equivalents - All cash, other than held in escrow, is maintained with a major financial institution in the United States. Deposits with this bank may exceed the amount of insurance provided on such deposits. Temporary cash investments with an original maturity of three months or less are considered to be cash equivalents. Cash and cash equivalents were $91,087 and $7,100 at October 31, 2013 and 2012, respectively.

Common stock	'
	Common stock - The Company records common stock issuances when all of the legal requirements for the issuance of such common stock have been satisfied.

Income Taxes	'
	Income Taxes - The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations. No deferred tax assets or liabilities were recognized as of October 31, 2013 or January 31, 2013.

Earnings (Loss) Per Share	'
	Earnings (Loss) Per Share - Basic loss per share is computed in accordance with ASC Topic 260, Earnings per Share, by dividing net loss attributable to common stockholders by the weighted average common shares outstanding for the period. Diluted loss per share is computed giving effect to all potentially dilutive common shares. Potentially dilutive common shares may consist of incremental shares issuable upon the exercise of stock options and warrants and the conversion of notes payable to common stock. In periods in which a net loss has been incurred, all potentially dilutive common shares are considered antidilutive and thus are excluded from the calculation. At October 31, 2013 and 2012, the Company did not have any potentially dilutive common shares.

Related Parties	'
	Related Parties - The Company follows ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Related party transactions for the periods ended October 31, 2013 and 2012 totaled $0.

Financial instruments	'
	Financial instruments - The Company's balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

	ASC 820, Fair Value Measurements and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:


		·	Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

		·	Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

		·	Level 3 - Inputs that are both significant to the fair value measurement and unobservable.

	Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of October 31, 2013. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include accounts receivable, other current assets, accounts payable, accrued compensation and accrued expenses. The fair value of the Company's notes payable is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements

	In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, to improve the transparency of reporting these reclassifications. Other comprehensive income includes gains and losses that are initially excluded from net income for an accounting period. Those gains and losses are later reclassified out of accumulated other comprehensive income into net income. The amendments in the ASU do not change the current requirements for reporting net income or other comprehensive income in financial statements. All of the information that this ASU requires already is required to be disclosed elsewhere in the financial statements under U.S. GAAP. The new amendments will require an organization to:



	·	Present (either on the face of the statement where net income is presented or in the notes) the effects on the line items of net income of significant amounts reclassified out of accumulated other comprehensive income - but only if the item reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period; and

	·	Cross-reference to other disclosures currently required under U.S. GAAP for other reclassification items (that are not required under U.S. GAAP) to be reclassified directly to net income in their entirety in the same reporting period. This would be the case when a portion of the amount reclassified out of accumulated other comprehensive income is initially transferred to a balance sheet account (e.g., inventory for pension-related amounts) instead of directly to income or expense.

	The amendments apply to all public and private companies that report items of other comprehensive income. Public companies are required to comply with these amendments for all reporting periods (interim and annual). The amendments are effective for reporting periods beginning after December 15, 2012, for public companies. Early adoption is permitted. The adoption of ASU No. 2013-02 is not expected to have a material impact on our financial position or results of operations.

	In January 2013, the FASB issued ASU No. 2013-01, Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which clarifies which instruments and transactions are subject to the offsetting disclosure requirements originally established by ASU 2011-11. The new ASU addresses preparer concerns that the scope of the disclosure requirements under ASU 2011-11 was overly broad and imposed unintended costs that were not commensurate with estimated benefits to financial statement users. In choosing to narrow the scope of the offsetting disclosures, the Board determined that it could make them more operable and cost effective for preparers while still giving financial statement users sufficient information to analyze the most significant presentation differences between financial statements prepared in accordance with U.S. GAAP and those prepared under IFRSs. Like ASU 2011-11, the amendments in this update will be effective for fiscal periods beginning on, or after January 1, 2013. The adoption of ASU 2013-01 is not expected to have a material impact on our financial position or results of operations.

CONVERTIBLE_NOTES_PAYABLE_Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	9 Months Ended
CONVERTIBLE NOTES PAYABLE (Tables)	Oct. 31, 2013
Convertible Promisorry Note dated February 28, 2013 [Member]	'
Debt Instrument [Line Items]	'
Schedule of Convertible Notes Payable	'


	Date	Amount Converted		Number of	Unamortized Discount
	Date	Amount Converted		Shares Issued	Unamortized Discount
	17-Sep-13	$	4,000	400,000	$	-
	1-Oct-13		4,000	400,000		1,300
	25-Oct-13		5,000	500,000		3,193

	Total	$	13,000	1,300,000	$	5,978
Convertible Promissory Note dated February 1, 2012 [Member]	'
Debt Instrument [Line Items]	'
Schedule of Convertible Notes Payable	'

	Date	Amount Converted		Number of	Unamortized Discount
	Date	Amount Converted		Shares Issued	Unamortized Discount
	6-Feb-13	$	4,900	490,000	$	3,920
	12-Mar-13		4,900	490,000		3,803
	20-Mar-13		5,900	590,000		4,503
	15-Apr-13		6,500	650,000		4,822
	3-May-13		3,250	325,000		2,281
	17-May-13		3,700	370,000		2,580
	22-May-13		3,700	370,000		2,494
	13-Jun-13		3,700	370,000		2,407
	14-Jun-13		4,000	400,000		2,489
	24-Jun-13		4,000	400,000		2,477
	1-Aug-13		4,000	400,000		1,312
	13-Aug-13		8,000	800,000		-

	Total	$	56,550	5,655,000	$	33,088

GENERAL_ORGANIZATION_AND_BUSIN1

GENERAL ORGANIZATION AND BUSINESS (Details) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended		34 Months Ended
GENERAL ORGANIZATION AND BUSINESS (Details) (USD $)	Jan. 31, 2011	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2012	Jan. 31, 2013	Jan. 31, 2012	Oct. 31, 2013
GENERAL ORGANIZATION AND BUSINESS [Abstract]	'	'	'	'	'	'	'	'
Non-refundable payment to Purlife	'	'	'	'	'	$5,000	'	'
Net loss	$2,600	$349,768	$98,077	$845,656	$282,046	$365,754	$81,216	$1,295,226

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended		34 Months Ended
GOING CONCERN (Details) (USD $)	Jan. 31, 2011	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2012	Jan. 31, 2013	Jan. 31, 2012	Oct. 31, 2013
GOING CONCERN [Abstract]	'	'	'	'	'	'	'	'
Net loss	$2,600	$349,768	$98,077	$845,656	$282,046	$365,754	$81,216	$1,295,226
Net cash used by operating activities	'	'	'	655,881	218,472	'	'	968,966
Negative working capital	'	'	'	$37,350	'	'	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details) (USD $)	9 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Jan. 31, 2013	Jan. 31, 2012	Jan. 10, 2011
SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES [Abstract]	'	'	'	'	'
Cash and cash equivalents	$91,087	$7,580	$7,100	$28,852	'
Related party transactions	'	'	'	'	'

JOINT_VENTURE_Details

JOINT VENTURE (Details) (USD $)

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Aug. 31, 2013

Jun. 05, 2013

30-May-13

Feb. 28, 2013

Oct. 31, 2013

Aug. 31, 2013

Oct. 31, 2013

30-May-13

Oct. 31, 2013

Jun. 05, 2013

Oct. 31, 2013

Neutra Corp. [Member]

Purlife [Member]

Second Wave Ventures LLC [Member]

Field of View Technologies, LLC. [Member]

Vertigo Technologies, LLC. [Membe]

Joint Venture [Line Items]

Joint venture profit percentage

30.00%

25.00%

10.00%

90.00%

Weekly Payments To Second Wave

$5,000

Total payments to second wave

30,000

Joint venture allocation period

'3 years

'36 months

Joint venture cash flow commitment

85,000

175,000

85,000

Joint venture cash flow contribution amount

$150,000

$55,000

$65,000

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	9 Months Ended		9 Months Ended
	Oct. 31, 2013	Jan. 31, 2013	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2012
	Sydney Jim [Member]	Sydney Jim [Member]	Cindy Morrissey [Member]	Cindy Morrissey [Member]	Sara Keck [Member]
Related Party Transaction [Line Items]	'	'	'	'	'
Accrued salary to officers	$75,000	'	$30,000	$62,500	$19,000
Unpaid salary and expenses	$5,700	'	'	'	'

CONVERTIBLE_NOTES_PAYABLE_Deta

CONVERTIBLE NOTES PAYABLE (Details) (USD $)	1 Months Ended			9 Months Ended
	Oct. 31, 2013	Jul. 31, 2013	Feb. 28, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013	Oct. 31, 2013
	Oct. 31, 2013	Jul. 31, 2013	Feb. 28, 2013	Convertible promissory note dated February 28, 2013 [Member]	Convertible promissory note dated July 31, 2013 [Member]	Convertible Promissory Note dated October 31, 2013 [Member]	Convertible Note Payable dated February 1, 2012 [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'
Debt instrument, face amount	'	'	'	$104,650	$338,815	$475,888	'
Debt instrument, interest rate	'	'	'	10.00%	10.00%	10.00%	'
Debt instrument, maturity date	'	'	'	28-Feb-15	31-Jul-15	31-Oct-15	'
Debt conversion, price per share	'	'	'	$0.01	$0.05	$0.05	$0.01
Beneficial conversion feature recognized on debt instrument	$475,888	$338,815	$104,650	'	'	'	'

CONVERTIBLE_NOTES_PAYABLE_Sche

CONVERTIBLE NOTES PAYABLE (Schedule of Convertible Notes Payable) (Details) (USD $)	9 Months Ended		34 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Debt Conversion [Line Items]	'	'	'
Amount Converted	$919,353	$43,495	$962,848
Convertible Promissory Note dated February 1, 2012 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	56,550	'	'
Number of Shares Issued	5,655,000	'	'
Unamortized Discount	33,088	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| February 6, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,900	'	'
Number of Shares Issued	490,000	'	'
Unamortized Discount	3,920	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| March 12, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,900	'	'
Number of Shares Issued	490,000	'	'
Unamortized Discount	3,803	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| March 20, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	5,900	'	'
Number of Shares Issued	590,000	'	'
Unamortized Discount	4,503	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| April 15, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	6,500	'	'
Number of Shares Issued	650,000	'	'
Unamortized Discount	4,822	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| May 3, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	3,250	'	'
Number of Shares Issued	325,000	'	'
Unamortized Discount	2,281	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| May 17, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	3,700	'	'
Number of Shares Issued	370,000	'	'
Unamortized Discount	2,580	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| May 22, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	3,700	'	'
Number of Shares Issued	370,000	'	'
Unamortized Discount	2,494	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| June 13, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	3,700	'	'
Number of Shares Issued	370,000	'	'
Unamortized Discount	2,407	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| June 14, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,000	'	'
Number of Shares Issued	400,000	'	'
Unamortized Discount	2,489	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| June 24, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,000	'	'
Number of Shares Issued	400,000	'	'
Unamortized Discount	2,477	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| August 1, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,000	'	'
Number of Shares Issued	400,000	'	'
Unamortized Discount	1,312	'	'
Convertible Promissory Note dated February 1, 2012 [Member] \| August 13, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	8,000	'	'
Number of Shares Issued	800,000	'	'
Unamortized Discount	'	'	'
Convertible Promisorry Note dated February 28, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	13,000	'	'
Number of Shares Issued	1,300,000	'	'
Unamortized Discount	5,978	'	'
Convertible Promisorry Note dated February 28, 2013 [Member] \| September 17, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,000	'	'
Number of Shares Issued	400,000	'	'
Unamortized Discount	'	'	'
Convertible Promisorry Note dated February 28, 2013 [Member] \| October 1, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	4,000	'	'
Number of Shares Issued	400,000	'	'
Unamortized Discount	1,300	'	'
Convertible Promisorry Note dated February 28, 2013 [Member] \| October 25, 2013 [Member]	'	'	'
Debt Conversion [Line Items]	'	'	'
Amount Converted	5,000	'	'
Number of Shares Issued	500,000	'	'
Unamortized Discount	$3,193	'	'

COMMON_STOCK_Details

COMMON STOCK (Details) (USD $)

1 Months Ended

9 Months Ended

12 Months Ended

Oct. 25, 2013

Oct. 01, 2013

Sep. 17, 2013

Aug. 13, 2013

Aug. 02, 2013

Jun. 24, 2013

Jun. 14, 2013

Jun. 13, 2013

22-May-13

17-May-13

3-May-13

Apr. 15, 2013

Mar. 20, 2013

Mar. 12, 2013

Feb. 06, 2013

Sep. 07, 2012

Aug. 08, 2012

Jun. 01, 2011

Jan. 31, 2011

Oct. 31, 2013

Jan. 31, 2013

Jan. 31, 2012

COMMON STOCK [Abstract]

Issuance of common stock to founder for cash, shares

450,000

Issuance of common stock to founder for cash

$9,000

Issuance of common stock for cash, shares

150,011

Issuance of common stock for cash

41,000

Reverse stock split description

'On August 8, 2012, the Company effected a one-for-20 reverse stock split.

Common stock issued for conversion of note payable

$5,000

$4,000

$8,000

$4,000

$3,700

$3,250

$6,500

$5,900

$4,900

$43,495

$69,550

$43,495

Common stock issued for conversion of note payable, shares

500,000

400,000

800,000

400,000

370,000

325,000

650,000

590,000

490,000

4,349,500

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)

1 Months Ended

9 Months Ended

12 Months Ended

34 Months Ended

1 Months Ended

Oct. 25, 2013

Oct. 01, 2013

Sep. 17, 2013

Aug. 13, 2013

Aug. 02, 2013

Jun. 24, 2013

Jun. 14, 2013

Jun. 13, 2013

22-May-13

17-May-13

3-May-13

Apr. 15, 2013

Mar. 20, 2013

Mar. 12, 2013

Feb. 06, 2013

Sep. 07, 2012

Oct. 31, 2013

Oct. 31, 2012

Jan. 31, 2013

Oct. 31, 2013

Dec. 04, 2013

Nov. 08, 2013

Subsequent Event [Member]

Subsequent Event [Line Items]

Common stock issued for conversion of note payable

$5,000

$4,000

$8,000

$4,000

$3,700

$3,250

$6,500

$5,900

$4,900

$43,495

$69,550

$43,495

$5,000

$4,000

Common stock issued for conversion of note payable, shares

500,000

400,000

800,000

400,000

370,000

325,000

650,000

590,000

490,000

4,349,500

500,000

400,000

Amortization of discount on convertible note payable

$119,957

$50,346

$172,936

$2,697

$2,435